M. Kalchman

发表

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

M. Hayden, B. Kremer, F. Squitieri, 1993, Nature Genetics.

Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression.

J. Rommens, M. Hayden, Y. P. Goldberg, 1993, Human molecular genetics.

Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme*

J. Hodgson, M. Hayden, Yoav Goldberg, 1996, The Journal of Biological Chemistry.

Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

M. Hayden, N. Thornberry, Y. P. Goldberg, 1996, Nature Genetics.

HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain

I. Kanazawa, M. Hayden, C. Wellington, 1997, Nature Genetics.

The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity

Michael R. Hayden, Abigail S. Hackam, A. Hackam, 1998, The Journal of cell biology.

Structural analysis of the 5' region of mouse and human Huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms.

M. Hayden, H. McDonald, Y. P. Goldberg, 1995, Genomics.

Identification of an Alu retrotransposition event in close proximity to a strong candidate gene for Huntington's disease

J. Rommens, M. Hayden, H. McDonald, 1993, Nature.

Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript.

J. O’Kusky, M. Hayden, C. Ross, 1996, Human molecular genetics.

Forskolin and dopamine D1 receptor activation increase Huntingtin's association with endosomes in immortalized neuronal cells of striatal origin

M. Hayden, J. Velier, A. Heller, 1999, Neuroscience.